Pädiatrie up2date, Table of Contents Pädiatrie up2date 2012; 07(04): 399-411DOI: 10.1055/s-0032-1325747 Gastroenterologie © Georg Thieme Verlag KG Stuttgart · New YorkRationelle Stuhldiagnostik Stephan Buderus Recommend Article Abstract Podcasts Buy Article All articles of this category Full Text References Literatur 1 Baker SS, Liptak GS, Coletti RB et al. Constipation in infants and children: evaluation and treatment (NASPGN medical position statement). J Pediatr Gastroenterol Nutr 1999; 29: 612-626 2 Weaver LT, Lucas A. Development of bowel habit in preterm infants. Arch Dis Child 1993; 68: 317-320 3 Weaver LT, Ewing G, Taylor LC. The bowel habit of milk-fed infants. J Pediatr Gastroenterol Nutr 1988; 7: 568-571 4 Ebach DR. Diarrhea. In: Bishop WP. Pediatric practice Gastroenterology. Columbus: McGraw-Hill; 2010: 41-54 5 Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-924 6 Chen SM, Chang MH, Du JC et al. Screening for biliary atresia by infant stool color card in Taiwan. Pediatrics 2006; 117: 1147-1154 7 Lien TH, Chang MH, Wu JF et al. Effects of the infant stool color card screening program on 5-year outcome of biliary atresia in Taiwan. Hepatology 2011; 53: 202-208 8 Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology 2009; 136: 1874-1886 9 Elliott EJ. Acute gastroenteritis in children. BMJ 2007; 334: 35-40 10 Guarino A, Albano F, Ashkenazi S et al. European Society for Paediatric Gastroenterology, Hepatology,and Nutrition/European Society for Paediatric Infectious Diseases. Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. JPGN 2008; 46: 81-122 11 Clark B, McKendrick M. A review of viral gastroenteritis. Curr Opin Infect Dis 2004; 17: 461-469 12 Wolffs PF, Bruggeman CA, van Well GT et al. Replacing traditional diagnostics of fecal viral pathogens by a comprehensive panel of real-time PCRs. J Clin Microbiol 2011; 49: 1926-1931 13 Guarino A, Giannattasio A. New molecular approaches in the diagnosis of acute diarrhea: advantages for clinicians and researchers. Current Opinion in Gastroenterology 2011; 27: 24-29 14 Sharp SE, Suarez CA, Duran Y et al. Evaluation of the Triage Micro Parasite Panel for detection of Giardia lamblia, Entamoeba histolytica/Entamoeba dispar, and Cryptosporidium parvum in patient stool specimens. J Clin Microbiol 2001; 39: 332-334 15 Leal YA, Cedillo-Rivera R, Simón JA et al. Utility of stool sample-based tests for the diagnosis of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr 2011; 52: 718-728 16 Fischbach W, Malfertheiner P, Hoffmann JC et al. S3-Leitlinie „Helicobacter pylori und gastroduodenale Ulkuskrankheit“ der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) in Zusammenarbeit mit der Deutschen Gesellschaft für Hygiene und Mikrobiologie, der Gesellschaft für pädiatrische Gastroenterologie und Ernährung e.V. und der Deutschen Gesellschaft für Rheumatologie – AWMF-Register-Nr. 021/001. Z Gastroenterol 2009; 47: 1230-1263 17 Fagerberg UL, Lööf L, Lindholm J et al. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2007; 45: 414-420 18 Kane SV, Sandborn WJ, Rufo PA et al. Fecal Laktoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol 2003; 98: 1309-1314 19 Joishy M, Davies I, Ahmed M et al. Fecal calprotectin and Laktoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2009; 48: 48-54 20 Enninger A, Buderus S. Chronsich-rezidiverende Bauchschmerzen – meist funktionell, seltener organisch. Vorschlag zur rationalen und rationellen Abklärung. Kinder- und Jugendarzt 2012; 43: 363-368 21 Sipponen T, Björkesten CG, Färkkilä M et al. Faecal calprotectin and Laktoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment. Scand J Gastroenterol 2010; 45: 325-331 22 Buderus S, Boone J, Lyerly D et al. Fecal Laktoferrin: A new parameter to monitor infliximab therapy. Dig Dis Sci 2004; 49: 1036-1039 23 Olafsdottir E, Aksnes L, Fluge G et al. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Paediatr 2002; 91: 45-50 24 Gishan FK. Chronic diarrhea. In: Kliegman RM, Behrman RE, Stanton BF. Nelson Textbook of pediatrics. Philadelphia: Saunders Elsevier; 2007: 1621-1626 25 Binder HJ. Causes of chronic diarrhea. N Engl J Med 2006; 355: 236-239 26 Kleinman RE. Chronic nonspecific diarrhea of childhood. Nestle Nutr Workshop. Ser Pediatr Program 2005; 56: 73-84 27 Park DI, Ryu S, Kim YH et al. Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 2010; 105: 2017-2025 28 Walkowiak J, Nousia-Arvanitakis S, Henker J et al. Indirect pancreatic function tests in children. J Pediatr Gastroenterol Nutr 2005; 40: 107-114 29 Leeds JS, Oppong K, Saunders DS. The role of fecal elastase‑1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol 2011; 8: 405-415 30 Benahmed NA, Manene D, Barbot L et al. Fecal pancreatic elastase in infants under 2 years of age. Ann Biol Clin (Paris) 2008; 66: 549-552 31 Braamskamp MJ, Dolman KM, Tabbers MM. Clinical practice. Protein-losing enteropathy in children. Eur J Pediatr 2010; 169: 1179-1185 32 Bindl L, Buderus S, Bindl C et al. Protein-loosing enteropathy: report of four cases and review of etiology, diagnostic work-up and treatment. Klin Padiatr 2005; 217: 201-210 33 Fujii T, Shimizu T, Takahashi K et al. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations. J Pediatr Gastroenterol Nutr 2003; 37: 577-580
